GDNF Receptor

(E)-Aminoquinol is a selective agonist of the GFRα-1 receptor. It mimics the neurotrophic effects of glial cell-derived neurotrophic factor (GDNF) and promotes Ret autophosphorylation in Neuro-2A cells. This compound is particularly relevant for research focused on neurodegenerative disorders such as Parkinson’s disease, facilitating studies on neuronal survival and growth pathways.

Aminoquinol is a GFRα-1 agonist that mimics the neurotrophic effects of glial cell line-derived neurotrophic factor (GDNF). It induces Ret autophosphorylation in Neuro-2A cells, promoting neuronal survival and differentiation. This compound is applicable in research concerning neurodegenerative disorders, particularly Parkinson's disease.

Aminoquinol phosphate is a GFRα-1 agonist that mimics the neurotrophic effects of glial cell-derived neurotrophic factor (GDNF). This compound induces Ret autophosphorylation in Neuro-2A cells, highlighting its potential role in neuroprotection. Aminoquinol phosphate is suitable for research applications related to Parkinson's disease and other neurodegenerative disorders, offering insights into mechanisms of neuronal survival and growth.

Aminoquinol triphosphate is a potent GFRα-1 agonist that induces neurotrophic effects akin to Glial Cell-Derived Neurotrophic Factor (GDNF). This compound promotes Ret autophosphorylation in Neuro-2A cells, making it a valuable tool in research focused on neurodegenerative disorders, particularly Parkinson's disease. Its mechanism of action positions it as a promising candidate for studies exploring neuroprotection and neuronal survival.